The Venture Codex Logo

The Venture Codex

Exelixis

1851 Harbor Bay Parkway, Alameda, CA, 94502, United States

Overview

Therapies for cancer and serious diseases through small molecule drugs.

Founded

1994

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

—

Geographic focus

—

Sector focus

Biotechnology
Health Care
Pharmaceutical

Investment portfolio

1rounds
NAMEDATESIZE
Yummy
Oct 2022Participated
$4 MOther Equity
Yummy
Oct 2022Participated
$4 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Exelixis: 1 funding rounds are recorded in the selected participation categories.All available history.
Exelixis: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity01

Monthly Deal Activity

Exelixis: 1 deals are recorded across 49 months.All available history.
Exelixis: 1 deals are recorded across 49 months. All available history
MonthDeals
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Exelixis: Food & Agriculture is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Exelixis: Food & Agriculture is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Food & Agriculture1
AI & Machine Learning1

Deal Size Distribution

Exelixis: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Exelixis: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Exelixis: 75306 has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Exelixis: 75306 has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
753061
Exelixis: 3 co-investors are shown, with DEPO Ventures sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Exelixis: 3 co-investors are shown, with DEPO Ventures sharing 1 recorded deals. All available history
Co-investorShared deals
DEPO Ventures1
Hatcher+1
Startup Wise Guys1

Investment Strategy

Exelixis: Led accounts for 0% and participating for 100% of round participation.All available history.
Exelixis: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating1100%
Exelixis: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Exelixis: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Amy Peterson

Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer

Christopher Senner

Executive Vice President and Chief Financial Officer

Gisela S. Schwab

Executive VP and Chief Medical Officer

Martin Schwickart

Director

Michael M. Morrissey

President and CEO

Pragalath Sundararajan

Scientist III, Discovery Biology

Stelios Papadopoulos

Founder

Vicki L. Goodman

EVP & Chief Medical Officer